A Harris administration would be detrimental to biomedical innovation

America is the world leader in biomedical innovation. And a Kamala Harris administration represents an existential threat to that discovery and innovation, which will cost lives and jobs.

Innovation has long been driven by robust intellectual property protections, strong federal investments in medical research funding and supportive tax and regulatory policies. America produces nearly twice as many drugs as our European counterparts and nearly four times as many as Japan. This leadership...